Meeting
2014 ASCO Annual Meeting
Validation study of graded prognostic assessment (GPA) of non-small cell lung cancer (NSCLC) patients with brain metastasis (BM).
Authors
Eberechi Sandra Agwa
Cleveland Clinic Foundation, Cleveland, OH
Eberechi Sandra Agwa , Samuel T. Chao , Lingling Du , Vyshak Alva Venur , Paul Elson , Gene H. Barnett , Lilyana Angelov , John H. Suh , Manmeet Singh Ahluwalia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 8116)
DOI
10.1200/jco.2014.32.15_suppl.8116
Abstract #
8116
Poster Bd #
297
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Use of brain radiotherapy as part of first course of treatment for NSCLC with de novo brain metastasis.
First Author: Rafael Arteta-Bulos
Poster
2021 ASCO Annual Meeting
Patterns of survival in NSCLC with de novo brain metastasis: SRS, WBRT, and no radiotherapy cohorts.
First Author: Diana Saravia
Poster
2014 ASCO Annual Meeting
A phase II study of whole brain radiotherapy with simultaneous integrated boost using volumetric modulated arc therapy for 1 to 10 brain metastases.
First Author: Alan Nichol
Poster
2023 ASCO Annual Meeting
Pretreatment clinical parameters associated with intracranial progression burden following an initial stereotactic radiosurgery course in a multi-institutional brain metastases cohort.
First Author: Christina C Huang